Brief CorrespondenceProstate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer
References (12)
- et al.
18F-Fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial
Lancet Oncol
(2019) - et al.
Integrative genomic profiling of human prostate cancer
Cancer Cell
(2010) - et al.
Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population
J Urol
(2013) - et al.
18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial
Lancet Oncol
(2019) - et al.
Genomic risk predicts molecular imaging-detected metastatic nodal disease in prostate cancer
Eur Urol Oncol
(2019) - et al.
EAU guidelines: prostate cancer
There are more references available in the full text version of this article.
Cited by (12)
Prognostic Value of PSMA PET/CT in Prostate Cancer
2024, Seminars in Nuclear MedicineContribution of the L-Type Amino Acid Transporter Family in the Diagnosis and Treatment of Prostate Cancer
2023, International Journal of Molecular SciencesUsing PSMA imaging for prognostication in localized and advanced prostate cancer
2023, Nature Reviews UrologyAlanine-Serine-Cysteine Transporter 2 Inhibition Suppresses Prostate Cancer Cell Growth In Vitro
2022, Journal of Clinical Medicine
- †
These authors contributed equally to this work.
© 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.